| Financial Year |
March 31 2023 |
| Monetary Funds |
1,574,778,964.82 |
| Held-for-trading Financial Assets |
791,062,558.79 |
| Notes Receivable |
168,178,117.45 |
| Accounts Receivable |
1,383,353,133.92 |
| Advances to Suppliers |
377,977,841.67 |
| Other Receivables |
58,652,651.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,372,588,197.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
69,875,886.20 |
| Total Current Assets |
6,446,914,954.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
344,090,239.02 |
| Investment Properties |
-- |
| Fixed Assetes |
1,228,363,792.71 |
| Under-construction Projects |
114,075,257.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
218,024,909.93 |
| R&D expenses |
-- |
| Goodwill |
813,853,733.99 |
| Long-Term Deferred and Prepaid Expenses |
9,058,184.45 |
| Deferred Income Tax Assets |
101,978,170.60 |
| Other Non-Current Assets |
35,464,276.08 |
| Sub-Total of Non-Current Assets |
4,036,873,438.36 |
| Total Assets |
10,483,788,392.57 |
| Short-Term Loans |
385,708,193.42 |
| Trading Financial liabilities |
-- |
| Notes Payable |
799,645,190.27 |
| Accounts Payable |
1,358,756,965.97 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
152,966,928.39 |
| Taxes Payable |
96,035,600.80 |
| Interest Payable |
-- |
| Dividend Payable |
144,000.00 |
| Other payables |
197,675,175.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
418,957,731.42 |
| Other Current Liabilities |
270,675,066.73 |
| Sub-Total of Current Liabilities |
4,722,282,644.34 |
| Long-term Loans |
72,050,300.65 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
28,451,398.09 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
159,245,840.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
379,057,676.33 |
| Total Liabilities |
5,101,340,320.67 |
| Paid-In Capital(Or Share Stock) |
745,837,804.00 |
| Capital Surplus |
434,334,885.41 |
| Surplus Reserve |
372,532,394.71 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,228,649,087.88 |
| Minority Stockholder's Interest |
344,480,707.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,037,967,364.56 |
| Owner's Equity（Stockholder's Equity） |
5,382,448,071.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,483,788,392.57 |
